Hikma intros ephedrine sulfateEphedrine sulfate injection had a market value of approximately $64 million in the 12 months ended November 2020, according to IQVIA. Dr. Reddy's intros generic SabrilThe Sabril brand and generic had a market value of approximately $141 million for the most recent 12 months ending in December 2020, according to IQVIA. Unichem gets FDA OK for generic Celebrex Unichem's generic Celebrex will be available in four dosage strengths: 50 mg, 100 mg, 200 mg, and 400 mg. Sandoz, Slayback Pharma partner to launch generic Firazyr Sandoz has signed a U.S. commercialization deal with Slayback Pharma to launch generic Firazyr (icatibant injection). ANI launches prazosin capsules Prazosin capsules had a market value of approximately $46.2 million, according to IQVIA. Upsher-Smith expands Access Pathways Program for commercially insured migraine patients Upsher-Smith has expanded its Access Pathways Program to offer commercially insured patients a $0 co-pay and free home delivery for acute and preventive migraine treatment options. Glenmark obtains FDA nod for generic Evekeo Evekeo tablets had a market value of approximately $21.5 million for the 12-month period ended November 2020, according to IQVIA. Smart Meter debuts cell-enabled iBloodPressure Monitor As it looks to grow its capabilities in enabling remote patient management, Smart Meter is introducing a new connected health tool. GeniusRx to automate home delivery service via McKesson's Central Fill as a Service Digital pharmacy GeniusRx will leverage McKesson's automated Central Fill as a Service to streamline distribution to customers. Unichem gets FDA nod for generic Zonegran Unichem's generic Zonegran provides a treatment for partial seizures in adult patients with epilepsy. First Previous 185 186 187 188 189 Next Last
